Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ROPINIROLE vs ROZANOLIXIZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ROPINIROLE vs ROZANOLIXIZUMAB: Safety Overview

Metric ROPINIROLE ROZANOLIXIZUMAB
Total FAERS Reports 4,239 303
Deaths Reported 310 9
Death Rate 7.3% 3.0%
Hospitalizations 1,192 114
Average Patient Age 65.5 yrs 61.3 yrs
% Female Patients 56.7% 60.9%
FDA Approval Date Apr 10, 2009 N/A
Manufacturer SOLCO HEALTHCARE US, LLC UCB, Inc.
Route ORAL SUBCUTANEOUS
Marketing Status Discontinued N/A